During the past decade, Piedmont Research Partners, LLC conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Piedmont Research Partners, LLC" #1 collaborator was "Teva Pharmaceutical Industries, Ltd." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Piedmont Research Partners, LLC" are "COPD" (1 trials), "Chronic Obstructive Pulmonary Disease" (1 trials), "Osteoarthritis, Hip" (1 trials) and "Osteoarthritis, Knee" (1 trials). Many other conditions were trialed in "Piedmont Research Partners, LLC" in a lesser frequency.

Most popular intervention types in "Piedmont Research Partners, LLC" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Celecoxib" (1 trials), "Diclofenac" (1 trials), "Fasinumab" (1 trials), "Lebrikizumab" (1 trials) and "Matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Piedmont Research Partners, LLC" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Piedmont Research Partners, LLC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Piedmont Research Partners, LLC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Piedmont Research Partners, LLC, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".